Skip to Content

Join the 'Attention-Deficit Hyperactivity Disorder (ADHD)' group to help and get support from people like you.

Attention-Deficit Hyperactivity Disorder (ADHD) News

Related terms: ADHD, Attention Deficit Disorder, Childhood hyperkinesis, ADD

Nearly a Third of College Kids Think ADHD Meds Boost Grades

Posted 1 day 5 hours ago by Drugs.com

MONDAY, Oct. 16, 2017 – Many college students who abuse ADHD drugs mistakenly believe that doing so will lead to better grades, a new survey suggests. Past research has found that college students commonly misuse stimulant medications such as Ritalin and Adderall as "study aids." That's despite the fact that there is no evidence the drugs help kids who do not have attention-deficit hyperactivity disorder (ADHD). The new study said that roughly 29 percent of students at nine U.S. colleges thought that stimulant medications boost school performance. Many others – 38 percent – were "unsure." And that misperception was especially common among students who admitted to abusing the drugs. Just over 11 percent said they'd used stimulant medication for "non-medical" reasons in the past six months. And of that group, almost two-thirds believed the drugs would improve their grades. The findings ... Read more

Related support groups: Anxiety and Stress, Adderall, Vyvanse, Attention-Deficit Hyperactivity Disorder (ADHD), Concerta, Ritalin, Adderall XR, Drug Dependence, Methylphenidate, Amphetamine, Methylin, Daytrana, Substance Abuse, Amphetamine/Dextroamphetamine, Metadate CD, Ritalin LA, Methylin ER, Lisdexamfetamine, Toxic Reactions Incl Drug and Substance Abuse, Evekeo

Neos Therapeutics Receives U.S. FDA Approval of Adzenys ER (amphetamine) Extended-Release Oral Suspension for ADHD

Posted 18 Sep 2017 by Drugs.com

DALLAS and FORT WORTH, Texas, Sept. 15, 2017 (GLOBE NEWSWIRE) – Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release products using its proprietary modified-release drug delivery technologies, today announced that the U.S. Food and Drug Administration (FDA) has approved Adzenys ER™ (amphetamine) Extended-Release Oral Suspension. Neos Therapeutics is the only company to offer both branded amphetamine and methylphenidate products in extended-release dosage forms. Once commercially available, Adzenys ER oral suspension will be the third Neos extended release product for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The other Neos extended-release products for the treatment of ADHD are Adzenys XR-ODT® (amphetamine) Extended-Release Orally Disintegrating Tablets and Cotempla XR ... Read more

Related support groups: Attention-Deficit Hyperactivity Disorder (ADHD), Amphetamine, Adzenys ER, Adzenys XR-ODT

Parents Say Schools Don't Help Kids With Mental Health, Chronic Disease

Posted 18 Sep 2017 by Drugs.com

MONDAY, Sept. 18, 2017 – Many parents don't believe schools are prepared to help students with mental health problems and serious physical health issues, a new survey finds. While 77 percent of parents were certain that schools would be able to provide first aid for minor issues such as cuts, they were less confident that schools could respond to more challenging health situations. For example, only 38 percent believed schools could assist a student suspected of having a mental health problem. The national poll on children's health was released Monday by the C.S. Mott Children's Hospital at the University of Michigan. "Parents feel schools can handle basic first aid, but are less sure about urgent health situations such as an asthma attack, epileptic seizure, or serious allergic reaction," Sarah Clark, poll co-director, said in a university news release. "And they have the most ... Read more

Related support groups: Depression, Anxiety, Bipolar Disorder, Anxiety and Stress, Major Depressive Disorder, Attention-Deficit Hyperactivity Disorder (ADHD), Schizophrenia, Borderline Personality Disorder, Oppositional Defiant Disorder, Dysthymia, Psychiatric Disorders, Anorexia, Aggressive Behavior

Back to School, Back to Planning for Kids With Autism, ADHD

Posted 4 Sep 2017 by Drugs.com

MONDAY, Sept. 4, 2017 – The start of a new school year isn't always easy, especially for kids with developmental and behavioral issues, such as autism and attention-deficit/hyperactivity disorder. Parents of these children may also have concerns about what lies ahead for their youngsters. But keeping a positive outlook is important for a smooth transition, according to Dr. Anson Koshy. "Starting a new school year is an exciting time, it can also be a source of anxiety to both parents and children, particularly for families with children with an autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD)," Koshy said. He is assistant professor and developmental pediatrician at McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth). "The sooner children with ASDs have access to evidence-based services and treatment, the more ... Read more

Related support groups: Attention-Deficit Hyperactivity Disorder (ADHD), Oppositional Defiant Disorder, Autism, Asperger Syndrome, Executive Function Disorder

Treating ADHD May Help Curb Later Drinking, Drug Problems

Posted 24 Jul 2017 by Drugs.com

MONDAY, July 24, 2017 – Teens and adults with attention-deficit/hyperactivity disorder may have a lower risk of developing an alcohol or drug problem if they take medications to treat their ADHD, a new study suggests. "This study contributes to growing evidence that ADHD medication is linked to lower risk for many types of harmful behavior, including substance abuse," said study leader Patrick Quinn. "The results also highlight the importance of careful diagnosis and compliance with treatment," he added. Quinn is a postdoctoral researcher at Indiana University's department of psychological and brain sciences. For the study, the researchers looked at data from 3 million Americans with ADHD. The risk of alcohol or drug abuse was 35 percent lower among men and 31 percent lower among women who took ADHD medications, such as Adderall, Ritalin and Strattera, than among those who did not take ... Read more

Related support groups: Oxycodone, Adderall, Hydrocodone, Tramadol, Methadone, OxyContin, Fentanyl, Opiate Dependence, Morphine, Vyvanse, Codeine, Attention-Deficit Hyperactivity Disorder (ADHD), Opana, Subutex, Concerta, Dilaudid, Ritalin, Adderall XR, Opana ER, Roxicodone

FDA Approves Mydayis (mixed salts of a single-entity amphetamine product) – A New Once-Daily Option for ADHD

Posted 21 Jun 2017 by Drugs.com

Lexington, Mass., USA – June 20, 2017 – Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the U.S. Food and Drug Administration (FDA) has approved Mydayis (mixed salts of a single-entity amphetamine product), a once-daily treatment comprised of three different types of drug-releasing beads for patients 13 years and older with Attention Deficit Hyperactivity Disorder (ADHD). Mydayis is not for use in children 12 years and younger. Shire expects to make Mydayis commercially available in the United States in the third quarter of 2017. The U.S. FDA approval of Mydayis is based on results from 16 clinical studies evaluating Mydayis in more than 1,600 subjects, including adolescents (aged 13 to 17 years) and adults with ADHD. In pivotal, placebo-controlled clinical studies, Mydayis significantly improved symptoms of ADHD, as measured by the ADHD-RS-IV and the Permanent Product Measure o ... Read more

Related support groups: Adderall, Attention-Deficit Hyperactivity Disorder (ADHD), Adderall XR, Amphetamine/Dextroamphetamine, Mydayis

Neos Therapeutics Announces FDA Approval of Cotempla XR-ODT (methylphenidate) Extended-Release Orally Disintegrating Tablets for the Treatment of ADHD in Patients 6 to 17 Years Old

Posted 21 Jun 2017 by Drugs.com

DALLAS and FORT WORTH, Texas, June 19, 2017 (GLOBE NEWSWIRE) – Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery and orally disintegrating tablet (ODT) technologies, today announced that the U.S. Food and Drug Administration (FDA) approved Cotempla XR-ODT, the first and only methylphenidate extended-release orally disintegrating tablet for the treatment of attention-deficit/hyperactivity disorder (ADHD) in patients 6 to 17 years old. “We are excited about the FDA approval of Cotempla XR-ODT, which offers patients and caregivers a new treatment option to manage the symptoms commonly associated with ADHD,” said Vipin K. Garg, Ph.D., President and CEO of Neos Therapeutics. “With this approval, Neos will be the only company to ... Read more

Related support groups: Attention-Deficit Hyperactivity Disorder (ADHD), Concerta, Ritalin, Methylphenidate, Methylin, Metadate CD, Ritalin LA, Methylin ER, Ritalin-SR, Quillivant XR, QuilliChew ER, Metadate ER, Cotempla XR-ODT, Aptensio XR

Teens With ADHD Face a Higher Crash Risk

Posted 12 Jun 2017 by Drugs.com

MONDAY, June 12, 2017 – As if parents don't worry enough when their teens drive the family car, new research shows that adolescents with attention-deficit/hyperactivity disorder (ADHD) are even more likely than their peers to have an accident. On a positive note, the higher risk was actually much lower than previously reported in earlier, small studies, the investigators added. "We found that adolescents with ADHD are 35 percent less likely to get licensed six months after they become eligible for a license as compared with other adolescents. [But] after acquiring a driver's license, adolescents with ADHD have an estimated 36 percent higher crash risk than other newly licensed teens," said study author Allison Curry. She is director of epidemiology and biostatistics at the Center for Injury Research and Prevention at Children's Hospital of Philadelphia (CHOP). Curry noted that higher ... Read more

Related support groups: Adderall, Vyvanse, Attention-Deficit Hyperactivity Disorder (ADHD), Adderall XR, Oppositional Defiant Disorder, Dextroamphetamine, Dexedrine, Amphetamine/Dextroamphetamine, Lisdexamfetamine, Dextrostat, ProCentra, Zenzedi, Liquadd, Executive Function Disorder

Are All Those 'Fidget Spinners' Really Helping Kids?

Posted 25 May 2017 by Drugs.com

THURSDAY, May 25, 2017 – Fidget spinners may be the latest must-have kids' toy, but claims that the gizmos help students pay attention aren't backed by science, experts say. Some retailers market the devices as a way to help kids with anxiety, autism or attention deficit hyperactivity disorder (ADHD) keep themselves calm and focused in the classroom. However, there have been no studies showing that fidget spinners benefit kids struggling to stay still, said Chicago psychiatrist Dr. Louis Kraus. "To the best of my knowledge, there's no science behind what they're advertising," said Kraus, chief of child and adolescent psychiatry for the Rush University Medical Center. "Without any research to show it's of benefit, I think it's wrong for them to advertise these things as helpful," he said. The claims likely are based on small-scale studies that show kids with ADHD pay better attention if ... Read more

Related support groups: Anxiety, Anxiety and Stress, Attention-Deficit Hyperactivity Disorder (ADHD), Oppositional Defiant Disorder, Autism, Asperger Syndrome, Executive Function Disorder

Car Crash Rate Falls When People With ADHD Take Meds

Posted 10 May 2017 by Drugs.com

WEDNESDAY, May 10, 2017 – If you have attention-deficit/hyperactivity disorder (ADHD), a new study suggests you would be wise to take your medication if you want to lower your chances of getting into a car accident. The "core symptoms" of ADHD are what boosts crash risk in the first place, explained study author Zheng Chang. Those include "inattention, hyperactivity and impulsivity," said Chang. He is a postdoctoral candidate in the department of medical epidemiology and biostatistics at the Karolinska Institute in Stockholm, Sweden. Other common ADHD-related behaviors – such as excessive risk-taking, poor control of aggression, and substance use – can make matters worse, he added. But "male ADHD patients had a 38 percent lower risk of motor vehicle crashes when receiving ADHD medication," Chang said. "And female patients had a 42 percent lower risk of motor vehicle crashes when ... Read more

Related support groups: Adderall, Vyvanse, Attention-Deficit Hyperactivity Disorder (ADHD), Concerta, Ritalin, Adderall XR, Oppositional Defiant Disorder, Methylphenidate, Dextroamphetamine, Dexedrine, Methylin, Daytrana, Amphetamine/Dextroamphetamine, Metadate CD, Ritalin LA, Methylin ER, Dextrostat, Ritalin-SR, Quillivant XR, ProCentra

Autism Greatly Boosts Kids' Injury Risk, Especially for Drowning

Posted 21 Mar 2017 by Drugs.com

TUESDAY, March 21, 2017 – Children with autism are at extremely high risk of drowning compared to other kids, a new study reveals. Analysis of death records found that kids with an autism spectrum disorder are 160 times more likely to die from drowning compared with the general pediatric population, the researchers reported. Children diagnosed with autism – usually between 2 and 3 years of age – need swimming lessons as soon as possible, even before they start other therapies that will improve the long-term quality of their lives, said senior author Dr. Guohua Li. "Pediatricians and parents should immediately help enroll the child in swimming classes, before any behavioral therapy, speech therapy or occupational therapy," said Li. He is a professor of epidemiology at Columbia University's Mailman School of Public Health in New York City. "Swimming ability for kids with autism is an ... Read more

Related support groups: Seizures, Attention-Deficit Hyperactivity Disorder (ADHD), Schizophrenia, Autism, Seizure Prevention, Asperger Syndrome, Seizure Prophylaxis

Could Common Insecticides Be Tied to Behavior Issues in Kids?

Posted 2 Mar 2017 by Drugs.com

THURSDAY, March 2, 2017 – Children exposed to a widely used group of insecticides may be at increased risk for behavioral problems, according to a new study. The insecticides are called pyrethroids. They're used on crops but can also be found in some mosquito repellents and in products used to treat head lice, scabies and fleas, the French research team explained. Like many types of insecticides, pyrethroids work by damaging nerves, and concerns have recently been raised about their possible effects on children who have been exposed. The study can't prove cause-and-effect. However, according to one child psychiatrist, it does raise troubling questions. "The pesticide class studied are considered 'safe' pesticides and this study is cause for concern as to how safe it really is," said Dr. Matthew Lorber, who reviewed the new findings. He directs child and adolescent psychiatry at Lenox ... Read more

Related support groups: Attention-Deficit Hyperactivity Disorder (ADHD), RID, Oppositional Defiant Disorder, Vitamin/Mineral Supplementation during Pregnancy/Lactation, Insect Bites, Lice Treatment, Pyrethrins, Labor and Delivery including Augmentation, Piperonyl Butoxide/Pyrethrins, Tegrin-LT Shampoo, Pronto Shampoo Kit, Lice Solution, Rid Pediculicide, Pronto with Metal Comb, End Lice Liquid, Rid Shampoo/Spray Kit, Pyrinyl II, Lice-X Liquid, Pyrinyl Liquid Shampoo, Pronto Lice Kill System

Imaging Study Confirms Brain Differences in People With ADHD

Posted 16 Feb 2017 by Drugs.com

WEDNESDAY, Feb. 15, 2017 – Researchers who pinpointed brain differences in people with attention-deficit/hyperactivity disorder (ADHD) say their findings show the condition should be considered a brain disorder. The international study – the largest of its kind – included more than 1,700 people with ADHD and more than 1,500 without the disorder. Participants were between the ages of 4 and 63. "We hope that this will help to reduce stigma that ADHD is 'just a label' for difficult children or caused by poor parenting. This is definitely not the case, and we hope that this work will contribute to a better understanding of the disorder," said study author Martine Hoogman. ADHD is characterized by inattention, overactivity and impulsivity that can interfere with learning and relationships. Brain scans revealed that five brain regions in those with ADHD were smaller than in those without ... Read more

Related support groups: Attention-Deficit Hyperactivity Disorder (ADHD), Oppositional Defiant Disorder, Head Imaging, Executive Function Disorder

Low-Income Kids More Likely to Have ADHD, Asthma

Posted 14 Feb 2017 by Drugs.com

TUESDAY, Feb. 14, 2017 – Children in families struggling to make ends meet are developing asthma and attention-deficit/hyperactivity disorder (ADHD) at faster rates than kids from families with greater means, a new study finds. On the other hand, kids from wealthier families are being diagnosed with autism spectrum disorder more often than children in poorer homes. But that likely indicates that those parents have better access to the health care services that can uncover an autism diagnosis, the study authors said. The findings suggest that family income and access to health insurance play a large role in a child's physical and mental health, said lead researcher Dr. Christian Pulcini. He's a pediatrics resident with the Children's Hospital of Pittsburgh. "Children in poverty are more at risk for adverse health outcomes, and we need to keep that in mind when we make policy and ... Read more

Related support groups: Adderall, Attention-Deficit Hyperactivity Disorder (ADHD), Asthma, Concerta, Ritalin, Adderall XR, Asthma - Maintenance, Oppositional Defiant Disorder, Methylphenidate, Amphetamine, Autism, Fluticasone, Qvar, Asthma - Acute, Budesonide, Methylin, Daytrana, Asperger Syndrome, Flovent, Entocort

Tiny Babies May Face Mental Health Problems Later

Posted 13 Feb 2017 by Drugs.com

MONDAY, Feb. 13, 2017 – Extremely low birth weight babies may be at increased risk for mental health problems later in life, a new review suggests. Researchers examined 41 studies conducted from 1990 to 2016. The studies included more than 2,700 extremely low birth weight babies (less than 1,000 grams, or just over 2 pounds) and more than 11,000 normal birth weight babies in the United States, Canada and 10 other countries. The extremely low birth weight babies had a higher risk for certain mental health problems. As children, they were more likely to have attention deficit hyperactivity disorder (ADHD), and as teens they had a greater risk of ADHD and social problems, the researchers found. Compared to adults who were born at a normal weight, those born at an extremely low weight had higher rates of anxiety, depression and shyness, and markedly lower levels of social functioning, ... Read more

Related support groups: Depression, Anxiety, Generalized Anxiety Disorder, Anxiety and Stress, Adderall, Attention-Deficit Hyperactivity Disorder (ADHD), Social Anxiety Disorder, Concerta, Ritalin, Adderall XR, Oppositional Defiant Disorder, Methylphenidate, Amphetamine, Autism, Dysthymia, Delivery, Psychiatric Disorders, Methylin, Daytrana, Asperger Syndrome

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Oppositional Defiant Disorder, Executive Function Disorder, Psychiatric Disorders

Related Drug Support Groups

Adderall, Vyvanse, bupropion, Concerta, Ritalin, Adderall XR, clonidine, Focalin, Strattera, view more... methylphenidate, dextroamphetamine, amphetamine, Focalin XR, methamphetamine, Dexedrine, Intuniv, imipramine, guanfacine, modafinil, 5-HTP, Methylin, Daytrana, Desoxyn, amphetamine / dextroamphetamine, tryptophan, Metadate CD, Ritalin LA, desipramine, amantadine, selegiline, Kapvay, desvenlafaxine, armodafinil, dexmethylphenidate, 5-hydroxytryptophan, Methylin ER, lisdexamfetamine, atomoxetine, Cylert, Dextrostat, Evekeo, pycnogenol, Ritalin-SR, ProCentra, Quillivant XR, Dyanavel XR, Desoxyn Gradumet, omega-3 polyunsaturated fatty acids, Mydayis, pemoline, QuilliChew ER, Cotempla XR-ODT, Adzenys XR-ODT, Adzenys ER, Metadate ER, Zenzedi, Aptensio XR, Selgene, Jumex, Atapryl, Carbex, Liquadd